Walleye Capital LLC Karyopharm Therapeutics Inc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.84 - $3.92 $293,675 - $405,355	-103,407 Reduced 64.59%	56,700 $220,000
Q4 2022 Feb 14, 2023	SELL	$2.48 - $5.93 $1.27 Million - $3.05 Million	-513,565 Reduced 76.23%	160,107 $544,000
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $4.37 Million - $6.24 Million	-1,071,743 Reduced 61.4%	673,672 $3.68 Million
Q2 2022 Aug 08, 2022	BUY	$4.15 - $8.37 $6.9 Million - $13.9 Million	1,662,337 Added 2000.94%	1,745,415 $7.87 Million
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $408,824 - $994,736	69,175 Added 497.55%	83,078 $612,000
Q4 2021 Mar 03, 2022	BUY	$5.21 - $8.61 $72,434 - $119,704	13,903 New	13,903 $89,000
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $352,584 - $536,310	-21,240 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $757,912 - $1.46 Million	-52,706 Reduced 71.28%	21,240 $408,000
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $682,521 - $1.45 Million	73,946 New	73,946 $1.42 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $53.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.